Germany’s health department reported an additional 21 people who recently received the AstraZeneca coronavirus vaccine suffered blood clots, The Associated Press reported.
Seven of the people who had blood clots connected with the AstraZeneca coronavirus vaccine have died, the Paul Ehrlich Institute, which is Germany’s federal medical regulatory body, told The Associated Press. Nineteen of the individuals affected by the blood clots were women while just two were men.
Several European countries resumed administering the AstraZeneca vaccine earlier this month after halting vaccinations due to blood clots, according to Science Magazine. Denmark, Iceland, Bulgaria, Luxembourg, Estonia, Lithuania and Latvia were among the nations to stop vaccinations using AstraZeneca doses. (RELATED: Countries Around The World Halt AstraZeneca Vaccine Over Blood Clot Worries)
German politician Winfried Kretschmann receives the AstraZeneca vaccine on March 19. (Marijan Murat/Pool/AFP via Getty Images)
The European Medicines Agency (EMA) ultimately reaffirmed the safety and efficacy of the vaccine, but said it couldn’t rule out the possibility that it caused rare blood clots, according to Science Magazine.
“The evidence we have is, at the moment, not sufficient to conclude with certainty whether these adverse events are indeed caused by the vaccine or not,” Sabina Straus, chair of the EMA’s Pharmacovigilance and Risk Assessment Committee.
The EMA recommended that patients and doctors were warned of possible side effects associated with the vaccine, according to the AP.
About 2.27 million AstraZeneca doses were given in Germany in the period when the 21 blood clot cases were reported.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.